Voyager Acquisition, Варрант (KYG93A7H1124, VACHW, VACHW.P)

Veraxa Biotech AG is a Switzerland-based company. The Company is primary engaged in biotechnology, advancing innovations in the field of antibody development and microfluidic technologies. The Company’s activities center on participating in and supporting businesses engaged in the screening of diagnostic and therapeutic antibodies, as well as their chemical or recombinant modification, formatting, validation, and preclinical and clinical development. In addition, the Company is involved in the commercialization and marketing of such solutions both domestically and internationally. The Company operates mainly through investments and strategic management of affiliated entities, providing services and oversight to companies within its portfolio.

• Veraxa Biotech Holding, акция обыкновенная, CH1476899161
• Veraxa Biotech Holding, Варрант, CH1478199107

• Чистая прибыль
• EBITDA
• Активы
• Капитал
• Чистый долг / EBITDA